Accordingly, pharmacological blockage of neuregulin (NRG) receptors present on microglia (associated with ALS disease progression) has been shown to slow disease advancement in an SOD1-ALS mouse model48. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.